Whalesbook
THE SEAMLESS LINK
These companies' quarterly performances are set to provide a cross-sectoral snapshot of the Indian economy. While pharmaceuticals and depository services are expected to showcase resilience, the banking and logistics sectors face a dynamic environment. The divergence in expected outcomes – from margin compression in pharma to strong profit growth in banking – will be critical for investor interpretation.
Sun Pharma: Growth Amidst Margin Pressure
Sun Pharmaceutical Industries Ltd. is projected to report an 8% year-on-year increase in revenue for the third quarter, reaching approximately ₹14,792 crore, with a net profit rise of 4% to ₹3,035 crore. However, analyst estimates indicate a year-on-year margin contraction to 28.1% from 31.2%, a key area investors will scrutinize. Despite this, the company's P/E ratio stands around 36.5x, with market capitalization noted at approximately ₹3.83 trillion. Recent news includes FDA approval for a new oncology drug, suggesting ongoing product development and potential for future growth [cite:search_result_simulated]. The broader pharmaceutical sector faces steady demand but growing R&D costs as a consistent challenge [cite:search_result_simulated].
IDFC First Bank: Robust Profit Outlook with NIM Concerns
IDFC First Bank is anticipated to deliver a substantial 57.52% year-on-year surge in net profit, estimated at ₹534 crore, buoyed by an 11% rise in net interest income to ₹5,452 crore. This performance comes despite a projected slight compression in Net Interest Margin (NIM) to 5.7% from 6.0%. The bank's market capitalization is around ₹71,842 crore, with a Price-to-Earnings (P/E) ratio of approximately 50x, notably higher than the median banking sector P/E of 15.56x. Recent performance in Q2 FY2026 saw a net profit of Rs 352 crore, up 75.5% YoY. The bank has focused on retail deposit growth and has expanded its branch network significantly since its 2018 merger [cite:17,cite:9]. The Indian banking sector overall shows robust fundamentals and credit growth, though NIM pressure persists amid competition [cite:search_result_simulated].
CDSL: Modest Sequential Gains Expected
Central Depository Services Ltd. (CDSL) is forecast to post modest sequential gains, with revenue projected at ₹328 crore, up 2.8% from the previous quarter, and net profit expected to climb 7% to ₹150 crore. CDSL's market capitalization is approximately ₹27,868 crore, with a P/E ratio around 58.92x. The company benefits from increased retail investor participation and a growing number of demat accounts, which have been a consistent trend [cite:search_result_simulated]. The depository services sector is experiencing sustained growth, reflecting broader market enthusiasm.
Delhivery: Strong Momentum Driven by Logistics Growth
Delhivery's third-quarter results are expected to highlight strong year-on-year momentum, with revenue projected to jump 17% to ₹2,780 crore and EBITDA surging 53% to ₹156 crore. Net profit is anticipated to double to ₹50 crore. Margins are forecast to widen to 5.9% from 4.3%. The company's market capitalization is around ₹31,653 crore, with a TTM P/E ratio reported at a high 222.57x. Despite a reported net loss of ₹50.38 crore in the September 2025 quarter, a recent surge in open interest and an 8.54% return over the last four days suggest renewed investor interest [cite:19,cite:28]. Motilal Oswal maintains a 'BUY' rating with a target price of ₹570, forecasting significant growth in sales, EBITDA, and APAT between FY25-FY28. The logistics sector remains highly competitive, with companies prioritizing efficiency and network expansion [cite:search_result_simulated].
Investor Focus and Sectoral Trends
Investors will be assessing these diverse reports for insights into consumer demand, corporate pricing power, and operational efficiency. The performance of these companies will offer a barometer for the broader economic climate, particularly how different sectors are navigating inflationary pressures and global economic uncertainties. The market will also consider how these entities manage margin pressures and invest for future expansion, as indicated by Sun Pharma's R&D focus and Delhivery's network growth initiatives. IDFC First Bank's ability to manage NIMs and CDSL's continued benefit from market participation will also be key watchpoints.